Table 3.
Results for guideline adherence in uncomplicated UTI episodes
| Category | Adherent, n (%) | Non-adherent, n (%) | Total episodes,n |
|---|---|---|---|
| Antibiotic | |||
| Total | 3712/6031 (62) | 2319/6031 (39) | 6031 |
| Nitrofurantoin | 3401/6031 (56) | 0/6031 (0) | 3401 |
| Trimethoprim | 168/6031 (3) | 0/6031 (0) | 168 |
| Ciprofloxacin | 80a/6031 (1) | 1582/6031 (26) | 1662 |
| Amoxicillin/clavulanic acid | 39a/6031 (1) | 364/6031 (6) | 403 |
| Trimethoprim/sulfamethoxazole | 28a/6031 (1) | 214/6031 (4) | 242 |
| Fosfomycin | 0/6031 (0) | 109/6031 (2) | 109 |
| Norfloxacin | 0/6031 (0) | 46/6031 (1) | 46 |
|
| |||
| Age groups, years | |||
| 18–39 | 391/613 (64) | 222/613 (36) | 613 |
| 40–64 | 1031/1708 (60) | 677/1708 (40) | 1708 |
| 65–79 | 1364/2194 (62) | 830/2194 (38) | 2194 |
| >80 | 930/1516 (61) | 586/1516 (39) | 1516 |
|
| |||
| Comorbidities | |||
| None | 1206/1900 (64) | 694/1900 (37) | 1900 |
| ≥1 | 2510/4131 (61) | 1621/4131 (39) | 4131 |
| Asthma/COPD | 596/983 (61) | 387/983 (39) | 983 |
| Diabetes | 876/1448 (61) | 572/1448 (40) | 1448 |
| Cardiovascular | 1449/2346 (62) | 897/2346 (38) | 2346 |
| Cancer | 591/1006 (59) | 415/1006 (41) | 1006 |
| Nephrological | 250/483 (52) | 233/483 (40) | 483 |
| Urological | 47/105 (45) | 58/105 (55) | 105 |
| Neurological | 58/97 (60) | 39/97 (40) | 97 |
| Immunocompromised | 250/438 (57) | 188/438 (43) | 438 |
a
Considered adherent because of treatment failure in 365 days prior to the current UTI episode. COPD = chronic obstructive pulmonary disease. UTI = urinary tract infection.